Showing 541 - 560 results of 944 for search '"central nervous system"', query time: 0.10s Refine Results
  1. 541

    Narrative Literature Review of Potential Atrial Fibrillation Mechanism of Action Induced by Discontinuation of Benzodiazepines by Agnė Okulevičiūtė, Gabija Laubner Sakalauskienė

    Published 2023-11-01
    “…They interact with GABA-A receptors, causing hyperpolarization and inhibitory effects in the central nervous system. BZDs are used to treat various clinical disorders, but long-term use can lead to adverse effects and withdrawal symptoms. …”
    Get full text
    Article
  2. 542

    Thioflavin-T: application as a neuronal body and nucleolar stain and the blue light photo enhancement effect by Jin-Hong Min, Heela Sarlus, Sho Oasa, Robert A. Harris

    Published 2024-10-01
    “…We believe that this is of value for any lab that studies central nervous system (CNS) tissues. Furthermore, we show that THT could potentially be used as a an alternative to the use of fluorescent reporters or other more costly RNA binding compounds in the study of nucleolar dynamics owing to its ability to clearly stain nucleoli in live cells. …”
    Get full text
    Article
  3. 543

    Dialectics and Implications of Natural Neurotropic Autoantibodies in Neurological Disease and Rehabilitation by A. B. Poletaev, A. A. Abrosimova, M. A. Sokolov, A. B. Gekht, V. V. Alferova, E. I. Gusev, T. Ya. Nikolaeva, C. Selmi

    Published 2004-01-01
    “…In particular, limited experimental evidence has been provided concerning the qualitative and quantitative serological response after acute injuries of the central nervous system or during chronic mental diseases. …”
    Get full text
    Article
  4. 544

    Electroencephalographic Features of Presumed Hepatic Encephalopathy in a Pediatric Dog with a Portosystemic Shunt—A Case Report by Raluca Adriana Ștefănescu, Vasile Boghian, Gheorghe Solcan, Mario Darius Codreanu, Mihai Musteata

    Published 2025-01-01
    “…Hepatic encephalopathy (HE) in dogs is a metabolic disorder of the central nervous system that occurs secondarily to liver dysfunctions, whether due to acquired or congenital causes. …”
    Get full text
    Article
  5. 545

    A Preliminary Investigation into the Neural Correlates of Knee Loading during a Change of Direction Task in Individuals after Anterior Cruciate Ligament Reconstruction by Adam Culiver, Dustin Grooms, Nathan Edwards, Laura Schmitt, James Oñate

    Published 2023-02-01
    “…# Background Central nervous system (CNS) function after ACLR, quantified by the blood oxygen level dependent (BOLD) response, is altered in regions of sensory function during knee movement after ACLR. …”
    Get full text
    Article
  6. 546

    Sodium Butyrate Protects N2a Cells against Aβ Toxicity In Vitro by Jingxuan Sun, Boyu Yuan, Yancheng Wu, Yuhong Gong, Wenjin Guo, Shoupeng Fu, Yongxin Luan, Wei Wang

    Published 2020-01-01
    “…Sodium butyrate (NaB) is a short-chain fatty acid salt that exerts neuroprotective effects such as anti-inflammatory, antioxidant, antiapoptotic, and cognitive improvement in central nervous system diseases. The aim of this study is to research the protective effects of NaB on neurons against Aβ toxicity and to uncover the underlying mechanisms. …”
    Get full text
    Article
  7. 547

    The antioxidant potential of bacoside and its derivatives in Alzheimer's disease: The molecular mechanistic paths and therapeutic prospects by Dipanjan Karati, Swarupananda Mukherjee, Souvik Roy

    Published 2025-06-01
    “…Central nervous system disorders are likely to have a substantial effect on the worldwide healthcare demands of humanity in this era. …”
    Get full text
    Article
  8. 548

    Identification and Validation of TEAD Family’s Prognostic Effects and Immune Microenvironment Regulations in Glioma by Zhengyuan Huo, Shaorui Gu, Zheng Bian, Wenli Wang, Zhifeng Jiang

    Published 2024-01-01
    “…Gliomas are primary malignant tumors of the central nervous system. The TEA domain transcription factor (TEAD) family proteins are the ultimate effector molecules of the Hippo pathway. …”
    Get full text
    Article
  9. 549

    Notch/CXCR4 Partnership in Acute Lymphoblastic Leukemia Progression by Georgia Tsaouli, Elisabetta Ferretti, Diana Bellavia, Alessandra Vacca, Maria Pia Felli

    Published 2019-01-01
    “…In children, there is 25% chance of disease relapse, typically in the central nervous system. While in adults, there is a higher chance of relapse. …”
    Get full text
    Article
  10. 550

    IGF-1 Restores Visual Cortex Plasticity in Adult Life by Reducing Local GABA Levels by José Fernando Maya-Vetencourt, Laura Baroncelli, Alessandro Viegi, Ettore Tiraboschi, Eero Castren, Antonino Cattaneo, Lamberto Maffei

    Published 2012-01-01
    “…The central nervous system architecture is markedly modified by sensory experience during early life, but a decline of plasticity occurs with age. …”
    Get full text
    Article
  11. 551

    Hyaluronan Synthesis, Catabolism, and Signaling in Neurodegenerative Diseases by Larry S. Sherman, Steven Matsumoto, Weiping Su, Taasin Srivastava, Stephen A. Back

    Published 2015-01-01
    “…The glycosaminoglycan hyaluronan (HA), a component of the extracellular matrix, has been implicated in regulating neural differentiation, survival, proliferation, migration, and cell signaling in the mammalian central nervous system (CNS). HA is found throughout the CNS as a constituent of proteoglycans, especially within perineuronal nets that have been implicated in regulating neuronal activity. …”
    Get full text
    Article
  12. 552

    Response to treatment with Interferon beta-1a in patients with relapsing-remitting multiple sclerosis by Làzaro Aurelio Vàzquez Gòmez, Carlos Hidalgo Mesa, Yunier Broche Pèrez, Yanet Valdés Morales

    Published 2022-10-01
    “…<p><strong>Background:</strong> multiple sclerosis modifying drugs are intended to reduce the frequency of relapses, delay the progression of disability, as well as the appearance of new lesions in the Central Nervous System.<br /><strong>Objective:</strong> to determine the early indicators of response to treatment with IFNb-1a.…”
    Get full text
    Article
  13. 553

    Coccidioidomycosis Masquerading as Eosinophilic Ascites by Kourosh Alavi, Pradeep R. Atla, Tahmina Haq, Muhammad Y. Sheikh

    Published 2015-01-01
    “…It can affect the central nervous system, bones, joints, skin, and, very rarely, the abdomen. …”
    Get full text
    Article
  14. 554

    The Potential for Cellular Therapy Combined with Growth Factors in Spinal Cord Injury by Jack Rosner, Pablo Avalos, Frank Acosta, John Liu, Doniel Drazin

    Published 2012-01-01
    “…Results are often limited because of the inhibitory environment created following the injury and the limited regenerative potential of the central nervous system. Therapies that show promise in small animal models may not transfer to nonhuman primates and humans. …”
    Get full text
    Article
  15. 555

    A nomogram for postoperative pain relief in patients with osteoporotic vertebral compression fracture treated with polymethylmethacrylate bone cement by Shirong Lu, Xudong Xia, Xu Shi, Xiaoli Qin, Chunguang Wang, Wei Wei

    Published 2025-01-01
    “…Four predictors were identified: number of segments, PMMA dose, comorbidities, and central nervous system (CNS) medications. The AUC, DCA, and calibration curves demonstrated good model discrimination and accuracy. …”
    Get full text
    Article
  16. 556

    The Association of the GABRP Polymorphisms with Systemic Lupus Erythematosus by Hun-Soo Kim, Eun-Heui Jin, Ji-Su Mo, Hyeok Shim, Shin-Seok Lee, Soo-Cheon Chae

    Published 2015-01-01
    “…Gamma-aminobutyric acid receptor subunit pi (GABRP) is involved in inhibitory synaptic transmission in the central nervous system. This gene encodes multisubunit chloride channels and is also expressed in numerous nonneuronal tissues such as the uterus and the ovaries. …”
    Get full text
    Article
  17. 557

    MRI findings in organophosphate-induced delayed neuropathy: A case report by Salma Moussaoui, Salma El Ouadih, Anas Orgi, Aicha Merzem, Hasna Belgadir, Omar Amriss, Nadia Moussali, Naima El Benna

    Published 2025-03-01
    “…MRI revealed diffuse hyperintensities in the corpus callosum, subcortical white matter, and other central nervous system structures, consistent with organophosphate-induced delayed neuropathy (OPIDN). …”
    Get full text
    Article
  18. 558

    Comparison between Sevoflurane and Isoflurane Effects on Hemodynamic Status by Adel Amen Hama

    Published 2022-03-01
    “… Back ground: Volatile anaesthetics are known to cause hypotension because of its effects on the central nervous system and autonomic nervous system, on the myocardium as well as its direct action on vascular smooth muscle. …”
    Get full text
    Article
  19. 559

    Bone Marrow-Derived, Neural-Like Cells Have the Characteristics of Neurons to Protect the Peripheral Nerve in Microenvironment by Shi-lei Guo, Zhi-ying Zhang, Yan Xu, Yun-xia Zhi, Chang-jie Han, Yu-hao Zhou, Fang Liu, Hai-yan Lin, Chuan-sen Zhang

    Published 2015-01-01
    “…The cells were injected into the distal end of severed rabbit peripheral nerves that were no longer integrated with the central nervous system. Electromyography (EMG), immunohistochemistry, and transmission electron microscopy (TEM) were employed to analyze the development of the cells in the peripheral nerve environment. …”
    Get full text
    Article
  20. 560

    Manganese Neurotoxicity as a Complication of Chronic Total Parenteral Nutrition by Alisha Khan, Jonathan Hingre, Amit S. Dhamoon

    Published 2020-01-01
    “…Manganese accumulation in the central nervous system creates clinical symptoms of cognitive dysfunction, behavioral changes, and movement disorders resembling Parkinson’s disease. …”
    Get full text
    Article